| 000 | 01659 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516023334.0 | ||
| 264 | 0 | _c20110802 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0016706 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThomas, Bobby | |
| 245 | 0 | 0 |
_aResistance to MPTP-neurotoxicity in α-synuclein knockout mice is complemented by human α-synuclein and associated with increased β-synuclein and Akt activation. _h[electronic resource] |
| 260 |
_bPloS one _cJan 2011 |
||
| 300 |
_ae16706 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 |
_aDopamine Agents _xpharmacology |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMPTP Poisoning _xprevention & control |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aNeurotoxicity Syndromes _xetiology |
| 650 | 0 | 4 |
_aNeurotoxins _xpharmacology |
| 650 | 0 | 4 |
_aOncogene Protein v-akt _xmetabolism |
| 650 | 0 | 4 |
_aalpha-Synuclein _xdeficiency |
| 650 | 0 | 4 |
_abeta-Synuclein _xphysiology |
| 700 | 1 | _aMandir, Allen S | |
| 700 | 1 | _aWest, Neva | |
| 700 | 1 | _aLiu, Ying | |
| 700 | 1 | _aAndrabi, Shaida A | |
| 700 | 1 | _aStirling, Wanda | |
| 700 | 1 | _aDawson, Valina L | |
| 700 | 1 | _aDawson, Ted M | |
| 700 | 1 | _aLee, Michael K | |
| 773 | 0 |
_tPloS one _gvol. 6 _gno. 1 _gp. e16706 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0016706 _zAvailable from publisher's website |
| 999 |
_c20583010 _d20583010 |
||